Dr Gerald DunstanPhD, MBA
SVP Corporate Development
Gerald leads our Corporate Development team working closely with current and potential partners from across biopharma and healthcare. Gerald is a molecular biologist by background and received his PhD under the Glaxo Scholarship scheme, developing methods for screening novel anti-microbial products. He spent several years working across drug discovery and development with pharma and biotech companies in the UK and North America, before moving into more commercially focused roles in consulting.
Gerald has spent the last twenty-five years advising pharma, biotech and healthcare providers and payers on a broad range of strategic, operational, and organisational topics. He was a junior partner in McKinsey & Company’s healthcare and pharma products practice, and a co-founder and Board member of the McKinsey Hospital Institute, led KPMG’s Healthcare & Life Sciences strategy practice and also developed advisory practices within large corporates including Medtronic and GE Healthcare. Prior to joining PrecisionLife Gerald served as Chief Strategy Officer at Prescient Healthcare Group.
Gerald is a passionate believer in the enormous potential that greater collaboration between technology, biopharma and healthcare providers and systems can bring.